The pathogenic HERV-W envelope protein represents a potential biomarker for monitoring CNS inflammation in MS and may influence immune responses to other viruses, impacting inflammatory pathways and potentially altering disease progression and outcomes. The gene discussed is ERVW-1; the disease is myeloid sarcoma.